| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |